Replies to post #442121 on NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Would you go after the full market potential of the GBM SOC which probably runs at 80-85% of all diagnosed, OR, would you want at best half of the patients that progress on the SOC, maybe 20-25% of the full market?

Seems like a lot of guacamole to me. Mucho bueno, guacamole con limon y tequila privada.

The current market estimate will grow substantially when a significant advance is offered. That is a lot of fresh guacamole we bought with those extra years. A whole lot of guacamole.

For simplification…

$5-6B x 0.75 = X 5 yrs =
$3.5B x 0.2 = X 9 years =

A whole lot of guacamole

[Chiugray]

That is most interesting. Could there be some synergy that comes with releasing TLD and medical journal publication at the same time, for marketing purposes, such that DCVax becomes more quickly accepted by the medical community as the standard of care treatment? Also helps insurance providers?